Isomorphic Labs Talks $40B Funding Round

Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40 billion. The round could value the company as highly as $50 billion, though the financing has not closed and details could change.